Stocks
Affimed (AFMD) R&D US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, € | 81 488 000 | 81 488 000 | 98 814 000 | 98 814 000 | 94 958 000 | 61 165 000 | |||
| Changes by years, y/y, % | +63% | 0% | +21% | 0% | -4% | +22.0% | |||
Affimed. R&D, €
Affimed. R&D, changes, %
Affimed. R&D, sum by quarters, €
Affimed (AFMD) R&D US GAAP (quarter values) |
||||||||
| 2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q1 | LTM ? | |||
| R&D, € | 21 498 000 | 15 391 000 | 18 656 000 | 11 727 000 | 15 391 000 | 61 165 000 | ||
| Changes by years, y/y, % | -18% | -44% | -54% | |||||
| Changes by quarters, q/q, % | -15% | -28% | +21% | -37% | +31% | |||
